Dana Andersen

CloudFlare Hosting Salesforce Gmail Outlook Google Apps MailChimp SPF Microsoft Office 365 Greenhouse.io Amazon AWS Drupal React Adobe Marketing Cloud Google Tag Manager YouTube New Relic Typekit Segment.io Mobile Friendly Google Analytics Sigma Remote Circle

biotechnology neurodegenerative disease neurodegeneration pharmaceuticals biotechnology: biological products (no diagnostic substances) health care biotechnology research neurodegenerative diseases therapeutic discovery blood-brain barrier biomarker-driven development clinical trials genetic pathways molecular therapeutics patient community alzheimer's disease parkinson's disease als frontotemporal dementia lysosomal storage diseases dnl310 technology engineered therapeutics drug candidates biotechnological innovations brain delivery systems crossing the blood-brain barrier target engagement pathway engagement patient phenotyping clinical development strategy therapeutics for mps ii therapeutics for mps iiia glial biology therapeutics targeting lrrk2 cellular homeostasis ripk1 inhibitors biologics for neurodegeneration small molecules for brain diseases patient partnering drug manufacturing quality assurance early clinical development preclinical studies therapeutic candidates clinical pipeline collaborations in neuroscience science-driven medicine investor relations scientific publications technological platforms partnering opportunities regulatory compliance clinical research biostatistics healthcare outcomes scientific advisory board innovative therapies biopharmaceuticals enzyme transport vehicles antibody transport vehicles protein transport vehicles oligonucleotide transport vehicles amyotrophic lateral sclerosis (als) hunter syndrome sanfilippo syndrome clinical-stage patient-centric approach scientific rigor transformative medicines unmet medical needs proprietary technology drug delivery healthcare providers patient communities market potential strategic partnerships cns diseases competitive landscape breakthrough therapy designation biologics license application (bla) commercial launch readiness therapeutic pipeline medical health wellness & fitness hospital & health care